GPR80/99, proposed to be the P2Y15 receptor activated by adenosine and AMP, is not a P2Y receptor
Open Access
- 1 December 2004
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 1 (1) , 67-74
- https://doi.org/10.1007/s11302-004-5069-0
Abstract
The orphan receptor GPR80 (also called GPR99) was recently reported to be the P2Y15 receptor activated by AMP and adenosine and coupled to increases in cyclic AMP accumulation and intracellular Ca2+ mobilization (Inbe et al. J Biol Chem 2004; 279: 19790–9[12]). However, the cell line (HEK293) used to carry out those studies endogenously expresses A2A and A2B adenosine receptors as well as multiple P2Y receptors, which complicates the analysis of a potential P2Y receptor. To determine unambiguously whether GPR80 is a P2Y receptor subtype, HA-tagged GPR80 was either stably expressed in CHO cells or transiently expressed in COS-7 and HEK293 cells, and cell surface expression was verified by radioimmunoassay (RIA). COS-7 cells overexpressing GPR80 showed a consistent twofold increase in basal inositol phosphate accumulation. However, neither adenosine nor AMP was capable of promoting accumulation of either cyclic AMP or inositol phosphates in any of the three GPR80-expressing cells. A recent paper (He et al. Nature 2004; 429: 188–93 [15]) reported that GPR80 is a Gq-coupled receptor activated by the citric acid cycle intermediate, α-ketoglutarate. Consistent with this report, α-ketoglutarate promoted inositol phosphate accumulation in CHO and HEK293 cells expressing GPR80, and pretreatment of GPR80-expressing COS-7 cells with glutamate dehydrogenase, which converts α-ketoglutarate to glutamate, decreased basal levels of inositol phosphates. Taken together, these data demonstrate that GPR80 is not activated by adenosine, AMP or other nucleotides, but instead is activated by α-ketoglutarate. Therefore, GPR80 is not a new member of the P2Y receptor family.Keywords
This publication has 28 references indexed in Scilit:
- Mechanisms of Release of Nucleotides and Integration of Their Action as P2X- and P2Y-Receptor Activating MoleculesMolecular Pharmacology, 2003
- Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg FamilyJournal of Biological Chemistry, 2003
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Differential coupling of the human P2Y11 receptor to phospholipase C and adenylyl cyclaseBritish Journal of Pharmacology, 2001
- The 6H1 Orphan Receptor, Claimed to Be the p2y5 Receptor, Does Not Mediate Nucleotide-Promoted Second Messenger ResponsesBiochemical and Biophysical Research Communications, 1997
- Lack of Nucleotide-Promoted Second Messenger Signaling Responses in 1321N1 Cells Expressing the Proposed P2Y Receptor, p2y7Biochemical and Biophysical Research Communications, 1997
- Early Expression of a Novel Nucleotide Receptor in the Neural Plate of Xenopus EmbryosPublished by Elsevier ,1997
- Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia CellsJournal of Biological Chemistry, 1996
- Identification of 6H1 as a P2YPurinoceptor: P2Y5Biochemical and Biophysical Research Communications, 1996
- Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.Proceedings of the National Academy of Sciences, 1994